KPIs & Operating Metrics(New)
Adjusted Ebitda By SegmentAdjusted Ebitda By Segment AnnualAdjusted Ebitda Margin By Segment %Adjusted Ebitda Margin By Segment Annual %Assets By Segment AnnualBreakdown Of AssetsClinics In Active DevelopmentCost Of Revenue BreakdownDeferred RevenueEmployee StatisticsFranchise License Sold AnnualFranchise License Sold AnnuallyGross Margin %Gross ProfitNew Patients Treated AnnualNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Income (Loss) By SegmentOperating Income (Loss) By Segment AnnualOperating Margin By Segment %Operating Margin By Segment Annual %Opex As A % Of Total Revenue %OPEX SegregationPatient Visits AnnualProperty And Equipment, Net BreakdownRemaining Performance Obligations AnnualRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue By Timing Of Transfer Of ServicesRevenue By Timing Of Transfer Of Services %Revenue By Timing Of Transfer Of Services AnnualRevenue By Timing Of Transfer Of Services Annual %Total Clinics In Operation At The End Of The Period
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Joint (JYNT) Gross Profit (2016 - 2025)

Joint's Gross Profit history spans 11 years, with the latest figure at $10.2 million for Q3 2024.

  • For Q3 2024, Gross Profit rose 12.78% year-over-year to $10.2 million; the TTM value through Sep 2024 reached -$13.0 million, down 126.48%, while the annual FY2023 figure was $38.3 million, 57.33% down from the prior year.
  • Gross Profit for Q3 2024 was $10.2 million at Joint, up from $9.2 million in the prior quarter.
  • Across five years, Gross Profit topped out at $24.0 million in Q3 2022 and bottomed at -$41.8 million in Q4 2023.
  • The 5-year median for Gross Profit is $13.7 million (2020), against an average of $11.8 million.
  • The largest annual shift saw Gross Profit soared 44.9% in 2021 before it crashed 286.95% in 2023.
  • A 5-year view of Gross Profit shows it stood at $15.1 million in 2020, then grew by 14.2% to $17.2 million in 2021, then increased by 29.59% to $22.3 million in 2022, then plummeted by 286.95% to -$41.8 million in 2023, then soared by 124.3% to $10.2 million in 2024.
  • Per Business Quant, the three most recent readings for JYNT's Gross Profit are $10.2 million (Q3 2024), $9.2 million (Q2 2024), and $9.5 million (Q1 2024).